Raks Pharma Pvt Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and WHO-GMP.
One of their notable products is CELECOXIB, USP, with a corresponding US DMF Number 25636.
Remarkably, this DMF maintains an Active status since its submission on December 28, 2011, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of April 23, 2014, and payment made on January 08, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II